Search hospitals > Illinois > Oak Lawn
Advocate Christ Medical Center
Claim this profileOak Lawn, Illinois 60453
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Heart Failure
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
225 reported clinical trials
29 medical researchers
Summary
Advocate Christ Medical Center is a medical facility located in Oak Lawn, Illinois. This center is recognized for care of Cancer, Breast Cancer, Heart Failure, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Advocate Christ Medical Center is involved with conducting 225 clinical trials across 306 conditions. There are 29 research doctors associated with this hospital, such as Rubina Qamar, Thomas J. Saphner, Antony Ruggeri, and Michael A Thompson.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
Rubina QamarAurora Saint Luke's Medical Center1 year of reported clinical research
Expert in Breast Cancer
Expert in Cancer
26 reported clinical trials
72 drugs studied
Thomas J. SaphnerAurora Saint Luke's Medical Center4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
21 reported clinical trials
46 drugs studied
Antony RuggeriAurora Cancer Care-Milwaukee West3 years of reported clinical research
Studies Cancer
Studies Solid Tumors
14 reported clinical trials
57 drugs studied
Michael A ThompsonAurora Cancer Care-Milwaukee West3 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
12 reported clinical trials
29 drugs studied
Clinical Trials running at Advocate Christ Medical Center
Breast Cancer
Lung Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Cancer
Rectal Cancer
Ovarian Cancer
Fallopian Tube Cancer
Recurrence
Oropharyngeal Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Advocate Christ Medical Center?
Advocate Christ Medical Center is a medical facility located in Oak Lawn, Illinois. This center is recognized for care of Cancer, Breast Cancer, Heart Failure, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Advocate Christ Medical Center is involved with conducting 225 clinical trials across 306 conditions. There are 29 research doctors associated with this hospital, such as Rubina Qamar, Thomas J. Saphner, Antony Ruggeri, and Michael A Thompson.